A 28-year-old man diagnosed with triple positive antiphospholipid syndrome (APS) and undergoing warfarin experienced three separate admissions to the cardiac ward within a one-month period due to escalating chest pain. While the initial two admissions revealed normal results in cardiological investigations, such as blood tests, electrocardiogram, and echocardiography, the third admission unveiled signs of ST-elevation myocardial infarction (STEMI), despite the patient maintaining an INR (International Normalized Ratio) of 4. Subsequent percutaneous coronary intervention (PCI) exposed spontaneous coronary artery dissection (SCAD) of type 3. Faced with hemodynamic instability and worsening symptoms, the patient underwent stenting and was prescribed dual antiplatelet therapy in addition to warfarin. A follow-up evaluation one month later indicated a normalization of his condition.
Keyphrases
- percutaneous coronary intervention
- antiplatelet therapy
- st elevation myocardial infarction
- st segment elevation myocardial infarction
- coronary artery
- acute coronary syndrome
- acute myocardial infarction
- coronary artery disease
- atrial fibrillation
- coronary artery bypass grafting
- case report
- pulmonary artery
- coronary artery bypass
- left ventricular
- emergency department
- venous thromboembolism
- heart failure
- pulmonary hypertension
- direct oral anticoagulants
- single cell
- computed tomography
- depressive symptoms